Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial

P. Geusens, D.L. Kendler, A. Fahrleitner-Pammer, P. Lopez-Romero, F. Marin

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)646-654
Number of pages9
JournalCalcified Tissue International
Volume106
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

Keywords

  • alendronate
  • back-pain
  • bisphosphonates
  • deformities
  • men
  • mortality
  • number
  • older women
  • osteoporosis
  • risedronate
  • risk
  • severity
  • spine
  • teriparatide
  • vertebral fractures
  • Risedronate
  • MORTALITY
  • Vertebral fractures
  • Spine
  • DEFORMITIES
  • Bisphosphonates
  • Osteoporosis
  • BACK-PAIN
  • NUMBER
  • RISK
  • ALENDRONATE
  • MEN
  • OLDER WOMEN
  • Teriparatide
  • SEVERITY

Cite this